ANTIBODIES TO LEUKEMIA DIFFERENTIATION FACTOR (HLDF) IN PATIENTS WITH GASTROINTESTINAL CANCER

Antibodies to leukemia differentiation factor (HLDF) in patients with gastrointestinal cancer Abstract. Patients with gastric cancer exhibit higher levels of IgG4-antibodies to human leukemia differentiation factor (HLDF), as compared with healthy individuals, whereas, in patients with colorectal ca...

Full description

Saved in:

Bibliographic Details
Published in:	Medit͡s︡inskai͡a︡ immunologii͡a Vol. 12; no. 1-2; pp. 49 - 56
Main Authors:	Autenshlus, A. I., Sosnina, A. V., Mikhailiva, E. S., Lykov, A. P., Tumanov, Yu. V., Danilanko, E. D., Samukov, V. S., Kostanyan, I. A., Morozov, D. V., Cherenkova, M. M., Thvan, L. .A., Varaksin, N. A.
Format:	Journal Article
Language:	English Russian
Published:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 08-07-2014
Subjects:	autoantibodies cytokines gastrointestinal cancer hdlf
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Antibodies to leukemia differentiation factor (HLDF) in patients with gastrointestinal cancer Abstract. Patients with gastric cancer exhibit higher levels of IgG4-antibodies to human leukemia differentiation factor (HLDF), as compared with healthy individuals, whereas, in patients with colorectal cancer, one may detect high levels of IgA anti-HDLF antibodies, along with lower levels of IgG1 class antibodies against HLDF than in control group. Among patients with gastrointestinal cancer, a positive correlation is revealed between contents of highly differentiated cells in the tumor, and IgM antibodies to HDLF. Meanwhile, a reverse relationship is noted between low differentiation of tumor cells and levels of IgG2 antibodies to HDLF in gastric cancer patients, or IgG3 antibodies to HDLF in patients with colorectal cancer.
ISSN:	1563-0625 2313-741X
DOI:	10.15789/1563-0625-2010-1-2-49-56